Disclosure: This site may earn affiliate commissions when you click provider links. This doesn't affect our recommendations. Learn more
An editorial review of Found's GLP-1 program. The real total cost (not the $149 headline), all 10 medications, and how it compares to Shed, Eden, and Hers.
Found is one of the most-discussed GLP-1 telehealth programs in the U.S., and one of the most misrepresented on price. The headline you see everywhere is "$149/month," but that figure is the medication only. Found charges a separate CORE membership on top, which means the actual total for the cheapest options lands between $248 and $298/month depending on how long you commit. The program itself is legitimate and well-built: 10 medications including the new Foundayo oral pill, a free insurance check, and a real care team with clinicians and coaches. The honest verdict is that Found is a strong fit for people who want a full program and may have insurance coverage, and a poor fit for people who just want cheap compounded medication and would skip the coaching layer.
Answer 10 questions and get a personalized recommendation.
Take the free quiz →Found is a full telehealth weight-management program built around GLP-1 medications, not a prescription mill. The clinical model wraps four layers around the prescription: a licensed clinician who reviews your intake and manages your care, a health coach who handles behavioral and adherence support, a behavior-change app for tracking and habits, and an AI lifestyle concierge for nutrition and lifestyle questions between visits.
The medication catalog is the broadest in the GLP-1 telehealth space. Found offers compounded semaglutide, compounded tirzepatide, and compounded liraglutide as injectables (none of which are FDA-approved as finished products). On the FDA-approved side, Found prescribes Foundayo (orforglipron, Eli Lilly's oral GLP-1 pill), the Wegovy pill, the Wegovy injectable pen, and the Zepbound KwikPen. Off-label, Found will prescribe Ozempic and Mounjaro at essentially retail pricing.
Two things to know before you read the pricing section. Found requires lab work to confirm GLP-1 eligibility, and lab work is not included in any of Found's monthly charges. Patients typically pay $50–$150 per panel out of pocket or through insurance. And state availability for compounded medications shifts as compounding regulations evolve, so confirm at intake which formulations are available where you live.
Found
From $248/mo all-in (May 2026)
Full program with insurance check, clinicians, coaches, and the broadest medication catalog in GLP-1 telehealth.
Most Found reviews repeat the marketing headline and stop there. Here is what actually happens at checkout.
Found's pricing has two components: the medication price and the CORE membership. The CORE membership covers the care team, the coaching, the app, and async messaging. It is billed separately from the medication and the rate depends on how long you commit.
| CORE membership tier | Monthly rate |
|---|---|
| 12-month plan | $99/mo |
| 6-month plan | $129/mo |
| 3-month plan | $139/mo |
| Month-to-month | $149/mo |
Prices throughout this article reflect what providers advertised as of May 2026 and may change. We verified Found's split-billing structure at intake in May 2026: the "$149/month" homepage figure is the medication price for the cheapest options, not the total charge.
Here is the full medication-by-membership matrix for self-pay patients:
| Medication | Medication price | Total (12-mo plan) | Total (month-to-month) |
|---|---|---|---|
| Compounded semaglutide (injectable) | $149/mo | $248/mo | $298/mo |
| Compounded tirzepatide (injectable) | $249/mo | $348/mo | $398/mo |
| Compounded liraglutide (daily injectable) | $149/mo | $248/mo | $298/mo |
| Foundayo (orforglipron oral pill, 0.8mg starter) | $149/mo | $248/mo | $298/mo |
| Wegovy pill | $198/mo | $297/mo | $347/mo |
| Wegovy injectable pen | $248/mo | $347/mo | $397/mo |
| Zepbound KwikPen | $348/mo | $447/mo | $497/mo |
| Mounjaro (off-label) | ~$1,100/mo | $1,199/mo | $1,249/mo |
| Ozempic (off-label) | ~$1,100/mo | $1,199/mo | $1,249/mo |
A few notes on this table. Foundayo escalates by dose: the $149/mo starter is for 0.8mg, with higher doses priced higher per LillyDirect's structure. The off-label Mounjaro and Ozempic prices are essentially retail because there is no manufacturer cash-pay program for either at weight-loss doses, so most patients in those rows would do better with the Wegovy pen at Found ($347/mo all-in on 12-month) or Zepbound directly from LillyDirect ($299–$449/mo).
Lab work is on top of all of this and runs $50–$150 per panel, typically once at intake and periodically thereafter.
The PLUS insurance pathway is a separate structure entirely. If you have insurance, Found's free insurance check tells you whether your plan covers a GLP-1. If it does, you enroll in PLUS at $39/month and pay your copay through the pharmacy. Found handles the prior authorization coordination, which can be the bottleneck that prevents patients from getting brand-name medication covered. Total cost on this pathway depends on your copay structure, but $39/mo plus a typical $25–$100 copay is materially cheaper than self-paying for any FDA-approved GLP-1.
Most GLP-1 telehealth providers offer two or three medications: usually compounded semaglutide, compounded tirzepatide, and one or two brand-name options. Found offers ten. That catalog breadth is a real differentiator.
The compounded options cover semaglutide, tirzepatide, and liraglutide as injectables. Compounded liraglutide is unusual: most providers stick to semaglutide and tirzepatide, and liraglutide's once-daily injection schedule makes it less commercially appealing. Found carrying it suggests the clinical model takes patient-specific dosing seriously, since liraglutide has a useful role for patients who don't tolerate the longer-acting GLP-1s.
The FDA-approved catalog is wide. Foundayo, Eli Lilly's once-daily oral pill, is one of the newest GLP-1 options on the market and Found is one of the few telehealth providers prescribing it. The Wegovy pill and Wegovy injectable pen cover both delivery preferences for Novo Nordisk's semaglutide. The Zepbound KwikPen rounds out the tirzepatide brand side.
The off-label Mounjaro and Ozempic rows are honestly more legal-coverage than value. Both run at retail pricing through Found because neither manufacturer offers a cash-pay program at weight-loss doses. If you specifically want Mounjaro or Ozempic at a real discount, no telehealth provider can deliver it. The realistic alternative is Wegovy pen for semaglutide or Zepbound for tirzepatide.
For a closer look at how the oral options compare, see our Foundayo vs Wegovy pill breakdown.
Found is built around the idea that GLP-1 medication is more effective when paired with structured behavioral support. The care team includes licensed clinicians who manage prescriptions, dose escalation, and side-effect monitoring, plus health coaches who handle the behavioral side. The Found app provides habit tracking, meal logging, and content modules. The AI lifestyle concierge fields the in-between questions that don't quite warrant a clinician message.
For patients new to GLP-1s, this structure delivers genuine value. Side effects like nausea, constipation, and reflux are common in the early weeks, and having a clinician proactively follow up on them can be the difference between staying on the medication and quitting. The coaching layer also matters for the part of GLP-1 outcomes that depends on diet quality and protein intake, especially for preserving lean mass.
For returning GLP-1 users who know what they're doing, the same structure can feel like overhead. If you don't plan to use the app, won't engage with coaching, and just want efficient access to medication, you'll pay $99–$149/month for services you don't use.
This is the part of Found that doesn't have a clean equivalent elsewhere in our roster.
Found's free insurance check happens before you pay anything. You submit your insurance information at intake, Found contacts the insurer, and you get back a written report of which GLP-1s your plan covers, what the prior-authorization requirements look like, and what your expected out-of-pocket would be. Most other providers leave this work to the patient, which in practice means most patients never figure out whether they're covered.
If you're covered, the PLUS pathway is $39/month for Found's coordination work, and the actual medication ships through your insurance and pharmacy at a copay. Found also handles the prior authorization paperwork, which routinely takes weeks if you try to do it yourself. For patients whose plans cover Wegovy or Zepbound but who have been stuck in PA limbo, this is the most direct path to coverage in the GLP-1 telehealth market.
For a broader look at coverage questions, see our GLP-1 insurance coverage guide.
Found's compounded semaglutide, tirzepatide, and liraglutide are not FDA-approved as finished products (FDA, 2024). They use the same active ingredients as Wegovy, Zepbound, and Saxenda, but the finished compounded formulations have not gone through FDA approval.
The regulatory landscape shifted significantly in late 2024 and 2025. The FDA declared the tirzepatide shortage resolved in October 2024 and the semaglutide shortage resolved in February 2025, with enforcement discretion ending in spring 2025 (FDA statement on compounders as GLP-1 supply stabilizes). Novo Nordisk and Eli Lilly have pursued legal action against compounding pharmacies and telehealth platforms over the past 18 months. Compounded access remains legal under specific circumstances, including documented clinical need based on dose or formulation, but the regulatory environment is less stable than it was a year ago.
None of this is unique to Found, but it is part of the calculus for choosing a compounded option through any telehealth provider.
Pros
Cons
Found fits if you:
Found does not fit if you:
Three providers cover overlapping ground in different ways.
Shed is the closest peer on catalog breadth. Shed offers compounded semaglutide and tirzepatide in injectable, sublingual lozenge, oral-drop, and oral liposomal tablet formats, plus brand Wegovy pill, Wegovy injectable, Zepbound, and Foundayo. Shed's brand-name pricing uses a $125/mo Shed Membership separate from medication, but the Wegovy pill total lands at $274/mo all-in versus Found's $297/mo. If you want the broadest format options or the cheapest verified brand Wegovy pill, Shed is the comparison to make.
Eden is the simpler, cheaper compounded option. Compounded semaglutide runs $129 first month and $209/month ongoing on a 3-month plan, with no separate membership. That is roughly $40–$90/month cheaper than Found's compounded sema total. Eden also facilitates brand Wegovy through NovoCare and brand Zepbound through LillyDirect. The trade-off: no behavioral coaching, no care team, no insurance-check service.
Hers is the brand-name-only alternative through a Novo Nordisk partnership. Hers prescribes Wegovy pill, Wegovy pen, Foundayo, Zepbound, Ozempic, and Mounjaro on a $149/month membership ($39 for the first month). Same structure as Hims but explicitly women-focused. For patients who don't want compounded and want a single membership covering the brand catalog, Hers is the cleaner path.
Shed
From $179/mo compounded, $274/mo Wegovy pill all-in (May 2026)
Closest catalog peer to Found, with broader format options and cheaper brand-name Wegovy pill.
For a full price-by-dose comparison across providers, see the cheapest semaglutide online breakdown or the live GLP-1 pricing tool.
Found is a legitimate, well-built program with the broadest medication catalog in GLP-1 telehealth and the strongest insurance support we've reviewed. The "$149/month" headline is misleading because Found bills the CORE membership separately, but the actual $248–$298/month total is competitive for what you get if you'll use the coaching and care-team layer. If you have insurance, the free insurance check and PLUS pathway can drop the all-in cost dramatically and is genuinely worth running before paying anyone for self-pay GLP-1.
If you want a flat-rate, minimal-support compounded program, Eden or TrimRx will save you money. If you want the broadest format options and slightly cheaper brand-name Wegovy pill, Shed is the closer fit. If you want brand-name-only with no compounded option, Hers covers that lane cleanly.
As with any GLP-1, talk to a licensed healthcare provider before starting or switching medications. Side-effect profiles, contraindications, and dose escalation all warrant a real clinical conversation, not just a checkout flow.
Found
From $248/mo all-in (May 2026)
Run the free insurance check before committing: it's the fastest way to know if you're covered.